Stock A8D AB SCIENCE
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases AB Science Deutsche Boerse AG

Equities

A8D

FR0010557264

Market Closed - Deutsche Boerse AG
Other stock markets
 08:02:49 24/05/2024 BST 		5-day change 1st Jan Change
2.09 EUR +3.47% Intraday chart for AB Science -3.24% -42.42%
05-13 AB Science: European patent granted for masitinib CF
05-03 AB Science: upbeat after legal success CF

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
AB Science reports its revenues for the year 2023 and provides an update on its activities
GL
AB Science announces issuance of a European patent for masitinib in the treatment of severe mastocytosis with protection until 2036
GL
AB Science : A new publication in the medical journal Muscle & Nerve validates the use of the rate of decline of ALSFR-S score (ΔFS) for the design of clinical studies and the treatment choice for amyotrophic lateral sclerosis (ALS) patient
GL
AB Science : The Paris Court of Appeal confirms the acquittal of the CEO of AB Science, Alain Moussy, and reduces the amount of the financial penalty imposed on AB Science
GL
AB Science announces a slight delay in the publication of its 2023 annual financial report
GL
AB Science announces a slight delay in the publication of its 2023 annual financial report
AQ
AB Science announces that Health Canada has granted eligibility for reconsideration request for masitinib in ALS
GL
AB Science: New research shows that masitinib limits neuronal damage in a model of neuroimmune-driven neurodegenerative disease
GL
AB Science: New research shows that masitinib limits neuronal damage in a model of neuroimmune-driven neurodegenerative disease
AQ
AB Science provides a summary of the live webcast held on March 4, 2024 giving an update on AB Science development
GL
AB Science provides a summary of the live webcast held on March 4, 2024 giving an update on AB Science development
AQ
AB Science announces that two financial analysis firms, DNA Finance and In Extenso Finance, have initiated coverage of the Company
GL
AB Science will host a live webcast on Monday March 4, 2024, from 6.30pm to 7.30pm CET
GL
AB Science will host a live webcast on Monday March 4, 2024, from 6.30pm to 7.30pm CET
GL
AB Science announces that Health Canada has issued a Notice of Non-Compliance-Withdrawal (NON/w) for masitinib in ALS
GL
AB Science announces an update in the marketing authorization application of masitinib in amyotrophic lateral sclerosis at the European Medicines Agency
GL
AB Science receives notice of allowance for European patent covering masitinib until 2036 in the treatment of mastocytosis
GL
AB Science will host a live webcast on Thursday November 30, 2023, from 3pm to 4pm CET, to present the masitinib development program in sickle cell disease
GL
AB Science: The clinical development of masitinib in sickle cell disease is among the 19 winning projects under the sixth call for “Hospital-Inuversity Research in health (RHU)”
GL
AB Science today reports its revenues for the first half of 2023 and provides an update on its activities
GL
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AB Stock
  4. A8D Stock
  5. News AB Science
  6. Press Releases